Pulmonary fibrosis results from the excessive deposition of collagen fibers and scarring in the lungs with or without an identifiable cause. The mechanism(s) underlying lung fibrosis development is poorly understood, and effective treatment is lacking. Here we compared mouse lung fibrosis induced by pulmonary exposure to prototypical particulate (crystalline silica) or soluble chemical (bleomycin or paraquat) fibrogenic agents to identify the underlying mechanisms. Young male C57BL/6J mice were given silica (2 mg), bleomycin (0.07 mg), or paraquat (0.02 mg) by pharyngeal aspiration. All treatments induced significant inflammatory infiltration and collagen deposition, manifesting fibrotic foci in silica-exposed lungs or diffuse fibrosis in bleomycin or paraquat-exposed lungs on day 7 post-exposure, at which time the lesions reached their peaks and represented a junction of transition from an acute response to chronic fibrosis. Lung genome-wide gene expression was analyzed, and differential gene expression was confirmed by quantitative RT-PCR, immunohistochemistry, and immunoblotting for representative genes to demonstrate their induced expression and localization in fibrotic lungs. Canonical signaling pathways, gene ontology, and upstream transcription networks modified by each agent were identified. In particular, these inducers elicited marked proliferative responses; at the same time, silica preferentially activated innate immune functions and the defense against foreign bodies, whereas bleomycin and paraquat boosted responses related to cell adhesion, platelet activation, extracellular matrix remodeling, and wound healing. This study identified, for the first time, the shared and unique genes, signaling pathways, and biological functions regulated by particulate and soluble chemical fibrogenic agents during lung fibrosis, providing insights into the mechanisms underlying human lung fibrotic diseases.
This is a preview of subscription content, log in to check access.
This work was funded to Q.M. by National Institute for Occupational Safety and Health, Health Effects Laboratory Division.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.
Bissonnette E, Rola-Pleszczynski M (1989) Pulmonary inflammation and fibrosis in a murine model of asbestosis and silicosis. Possible role of tumor necrosis factor. Inflammation 13(3):329–339CrossRefPubMedGoogle Scholar
Huang CH, Mirabelli CK, Jan Y, Crooke ST (1981) Single-strand and double-strand deoxyribonucleic acid breaks produced by several bleomycin analogues. Biochemistry 20(2):233–238CrossRefPubMedGoogle Scholar
Huaux F, Liu T, McGarry B, Ullenbruch M, Phan SH (2003) Dual roles of IL-4 in lung injury and fibrosis. J Immunol 170(4):2083–2092CrossRefPubMedGoogle Scholar
Husain AN, Kumar V (2005) The lung. In: Kumar V, Abbas AK, Fausto N (eds) Robbins and Cotran pathologic basis of disease, 7th edn. Elsevier Saunders, Philadelphia, pp 711–772Google Scholar
Iqbal N, Choudhary R, Chan J, Wentworth B, Higginbotham E, Maisel AS (2013) Neutrophil gelatinase-associated lipocalin as diagnostic and prognostic tool for cardiovascular disease and heart failure. Expert Opin Med Diagn 7(2):209–220. doi:10.1517/17530059.2013.763795CrossRefPubMedGoogle Scholar
Lopez MF, Tollervey J, Krastins B et al (2012) Depletion of nuclear histone H2A variants is associated with chronic DNA damage signaling upon drug-evoked senescence of human somatic cells. Aging 4(11):823–842PubMedCentralPubMedGoogle Scholar
Makris K, Kafkas N (2012) Neutrophil gelatinase-associated lipocalin in acute kidney injury. Adv Clin Chem 58:141–191CrossRefPubMedGoogle Scholar
Raghu G, Collard HR, Egan JJ et al (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183(6):788–824. doi:10.1164/rccm.2009-040GLCrossRefPubMedGoogle Scholar
Tounekti O, Pron G, Belehradek J Jr, Mir LM (1993) Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res 53(22):5462–5469PubMedGoogle Scholar
Udalova IA, Ruhmann M, Thomson SJ, Midwood KS (2011) Expression and immune function of tenascin-C. Crit Rev Immunol 31(2):115–145CrossRefPubMedGoogle Scholar
Zani ML, Tanga A, Saidi A et al (2011) SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions. Biochem Soc Trans 39(5):1441–1446. doi:10.1042/BST0391441CrossRefPubMedGoogle Scholar
1.Receptor Biology Laboratory, Toxicology and Molecular Biology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and HealthCenters for Disease Control and PreventionMorgantownUSA
2.Department of BiostatisticsYale University School of Public HealthNew HavenUSA
3.Pathology and Physiology Research Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and HealthCenters for Disease Control and PreventionMorgantownUSA
4.Biostatistics and Epidemiology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and HealthCenters for Disease Control and PreventionMorgantownUSA